|
|
|
|
Roche looks to pipeline, new diseases for growth
Yesterday, Roche concluded its first pipeline update following last year's acquisition of Genentech.As expected, the Swiss drugmaker highlighted its late-stage drug pipeline (chart), noting that its positioned to launch six new therapies by the end of 2014....
|
|
|
Roche Increased Avastin Sales Efforts; Doubles Us Force
NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said Thursday that it expects the effort to...
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said...
|
|
|
The Rush To Buy ImmunoGen
ImmunoGen (IMGN) soared on Thursday, after investors saw Forbes senior editor Robert Langreth's article about pharmaceutical company Roches status and plans.In the article, Severin Schwan, Roches chief executive, discussed his firms dominant position in the...
|
|
|
The Drugs Are Working For Roche
Roches investor day left little doubt about the Swiss pharmaceutical giants conviction that its experimental drug pipeline will keep it on the path of success.The firm touted that about ten experimental medicines could reach annual sales of more than 2...
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
_ Roche Increased Avastin Sales Efforts; Doubles US Force.
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said Thursday that it expects the effort to...
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said Thursday that it expects the effort to...
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said Thursday that it expects the effort to...
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said Thursday that it expects the effort to...
|
|
|
Roche Increased Avastin Sales Efforts; Doubles US Force
NEW YORK -(Dow Jones)- Roche Holding AG (RHHBY, ROG.VX) increased its efforts to sell its top-selling Avastin cancer treatment earlier this year, doubling the number of people pushing the drug in the U.S., and said Thursday that it expects the effort to...
|
|
|
Roche CEO: Nobody Can Touch Avastin
Roche is in such a dominant position in the cancer drug market that it will be hard for competitors to touch it, says Severin Schwan, the company's mild-mannered chief executive.The main reason: it will be hard for companies like Pfizer, AstraZeneca, and...
|
|
|
Roche CEO: Nobody Can Touch Avastin
Roche is in such a dominant position in the cancer drug market that it will be hard for competitors to touch it, says Severin Schwan, the company's mild-mannered chief executive.The main reason: it will be hard companies like Pfizer, AstraZeneca, and Sanofi...
|
|
|
Roche aiming to launch 6 new products by end 2014
ZURICH (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.Roche, the world's largest maker...
|
|
|
Roche aiming to launch 6 new products by end 2014
42 mins ago ZURICH (Reuters) Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.Roche, the world's...
|
|
|
UPDATE 2-Roche aiming to launch 6 new products by end 2014
ZURICH, March 18 (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.Roche, the world's...
|
|
|
Roche aiming to launch 6 new products by end of 2014
ZURICH (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and is seeking to further boost its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.Roche, the world's largest maker...
|
|
|
Roche aiming to launch 6 new products by end 2014
How to save your taxes and manage your investments Roche, the world's largest maker of cancer drugs, is aiming to build up its strength in the therapeutic areas of metabolism, inflammation and diseases of the central nervous system (CNS) as it tries to expand...
|
|
|
UPDATE 2-Roche aiming to launch 6 new products by end 2014
* Roche looks to further build up presence outside oncology * May file 35 line extensions of current products by 2014 * Roche stock rises 0.7 percent, in line with index (Adds analyst comment, stock price) ZURICH, March 18 (Reuters) - Roche Holding AG <ROG...
|
|
|
UPDATE 2-Roche aiming to launch 6 new products by end 2014
* Roche looks to further build up presence outside oncology * May file 35 line extensions of current products by 2014 * Roche stock rises 0.7 percent, in line with index (Adds analyst comment, stock price) ZURICH, March 18 (Reuters) - Roche Holding AG (ROG.VX...
|
|
|
Roche aiming to launch 6 new products by end of 2014
How to save your taxes and manage your investments Roche, the world's largest maker of cancer drugs, is aiming to build up its strength in the therapeutic areas of metabolism, inflammation and diseases as it tries to expand its current product portfolio.
|
|
|
Roche aiming to launch 6 new products by end of 2014
Roche, the world's largest maker of cancer drugs, is aiming to build up its strength in the therapeutic areas of metabolism, inflammation and diseases as it tries to expand its current product portfolio.Investors are looking to the group for reassurance...
|
|
|
Roche aiming to launch 6 new products by end of 2014
19 mins ago ZURICH (Reuters) Roche Holding AG is aiming to launch at least six new products by the end of 2014 and its seeking to strengthen its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.Roche, the world's largest...
|
|
|
Roche aiming to launch 6 new products by end of 2014
ZURICH, March 18 (Reuters) - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and its seeking to strengthen its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.Roche, the world's largest...
|
|
|
Roche to Introduce Six New Medicines By End 2014 (Update1)
(Adds company comment from second paragraph.) March 18 (Bloomberg) -- Roche Holding AG plans to strengthen its position in oncology and expand in therapeutic areas such as metabolism and inflammation, introducing at least six new medicines by 2015.Roche is...
|
